We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
193 hedge funds and large institutions have $1.2B invested in Corcept Therapeutics in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 67 increasing their positions, 62 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
53% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 19
25% more capital invested
Capital invested by funds: $962M → $1.2B (+$241M)
5% more funds holding
Funds holding: 183 → 193 (+10)
8% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 62
6% more call options, than puts
Call options by funds: $4.41M | Put options by funds: $4.15M
0.24% less ownership
Funds ownership: 75.12% → 74.88% (-0.24%)
Holders
193
Holders Change
+10
Holders Change %
+5.46%
% of All Funds
4.23%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
29
Increased
67
Reduced
62
Closed
19
Calls
$4.41M
Puts
$4.15M
Net Calls
+$263K
Net Calls Change
-$1.68M
Top Buyers
| 1 |
PA
Parallel Advisors
San Francisco,
California
|
+$15.7M |
| 2 |
Renaissance Technologies
New York
|
+$11.5M |
| 3 |
LSV Asset Management
Chicago,
Illinois
|
+$6.57M |
| 4 |
Millennium Management
New York
|
+$6.34M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$2.88M |
Top Sellers
| 1 |
CCM
Consonance Capital Management
New York
|
-$32.1M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$12.6M |
| 3 |
Morgan Stanley
New York
|
-$6.93M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$5.04M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$3.67M |
